Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apoptosis Regulatory Proteins”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Testing effectiveness (Phase 2)UnknownNCT03753243
What this trial is testing

Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Mark Garzotto, MD 32
Early research (Phase 1)Looking for participantsNCT07161414
What this trial is testing

Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

Who this might be right for
Advanced Solid Tumors
AstraZeneca 40
Testing effectiveness (Phase 2)UnknownNCT05915481
What this trial is testing

Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors

Who this might be right for
Advanced Solid TumorStereotactic Body RadiotherapyImmune Checkpoint Inhibitor+2 more
Peking University Third Hospital 60
Not applicableStudy completedNCT06865976
What this trial is testing

Genomic and Proteomic Analyses of Apoptosis Mechanisms in Diseased Peri-implant Tissue

Who this might be right for
ApoptosisApoptosis Regulatory ProteinsProteases+1 more
Sakarya University 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT06502977
What this trial is testing

Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 32
Testing effectiveness (Phase 2)Ended earlyNCT03116529
What this trial is testing

Neoadjuvant Durvalumab and Tremelimumab Plus Radiation for High Risk Soft-Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University of Maryland, Baltimore 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT06638931
What this trial is testing

Agnostic Therapy in Rare Solid Tumors

Who this might be right for
Urachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more
Instituto do Cancer do Estado de São Paulo 28
Early research (Phase 1)WithdrawnNCT03920839
What this trial is testing

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

Who this might be right for
Advanced and/or Metastatic Solid TumorsStage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung CancerAdvanced/Metastatic Unresectable Malignant Pleural Mesothelioma
Incyte Corporation
Testing effectiveness (Phase 2)Looking for participantsNCT06413680
What this trial is testing

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

Who this might be right for
MelanomaClear-Cell Renal-Cell Carcinoma (ccRCC)Advanced Solid Tumors
Regeneron Pharmaceuticals 240
Testing effectiveness (Phase 2)Study completedNCT02735239
What this trial is testing

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Who this might be right for
Esophageal Cancer
Ludwig Institute for Cancer Research 73
Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Testing effectiveness (Phase 2)Study completedNCT03179436
What this trial is testing

Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)

Who this might be right for
Advanced Solid Tumors
Merck Sharp & Dohme LLC 415
Testing effectiveness (Phase 2)Study completedNCT04997850
What this trial is testing

The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectableTransarterial ChemoembolizationTyrosine Kinase Inhibitor+1 more
Xinrui Zhu，MD 142
Testing effectiveness (Phase 2)UnknownNCT04885413
What this trial is testing

An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients

Who this might be right for
Recurrent/ Advanced Stage Endometrial Cancer Patients
Sun Yat-sen University 37
Large-scale testing (Phase 3)Ended earlyNCT03348904
What this trial is testing

Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Incyte Corporation 2
Testing effectiveness (Phase 2)Study completedNCT02549209
What this trial is testing

Pembro/Carbo/Taxol in Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Daniela Matei, MD 46
Early research (Phase 1)Ended earlyNCT03716596
What this trial is testing

SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University 8
Testing effectiveness (Phase 2)Ended earlyNCT04319224
What this trial is testing

Vopratelimab (JTX-2011) Alone and in Combination With Anti-Programmed Cell Death Protein 1 (PD-1) or Anti-Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) in Subjects With Advanced and/or Refractory Solid Tumors

Who this might be right for
Cancer
Jounce Therapeutics, Inc. 4
Testing effectiveness (Phase 2)Study completedNCT01272466
What this trial is testing

Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma

Who this might be right for
Relapsed Multiple Myeloma
Herlev Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04483219
What this trial is testing

Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.

Who this might be right for
MSSpMMRMetastatic Colorectal Adenocarcinoma
China Medical University, China 53
Load More Results